Funding for this research was provided by:
This investigator-initiated study was funded by Metagenics, Inc.
Received: 13 February 2019
Revised: 4 September 2019
Accepted: 9 September 2019
First Online: 24 September 2019
: O.H. is on the advisory board of AstraZeneca and Sanofi-Aventis U.S. LLC and is a consultant to Merck & Co., Inc. and Abbott Nutrition. He is a shareholder of Healthimation, Inc. and receives research grants from the National Dairy Council and Novo Nordisk. M.J.A. is on the advisory boards of Novo Nordisk and WebMD Health Services and owns stock in Health IQ. A.M., D.M.P., R.P., A.H.E., S.T. and S.A. declare no conflict of interest.